-
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
Wednesday, July 27, 2022 - 7:00pm | 1148IDEAYA Biosciences (NASDAQ: IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193 in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of...
-
Lexicon Pharmaceuticals Shares Plunge On Proposed Public Offering
Wednesday, July 27, 2022 - 5:42pm | 167Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares dropped 18% in the after-hours session on commencing an underwritten public offering to offer and sell shares of its common stock, par value of $0.001. Lexicon intends to grant the underwriters a 30-day option to purchase...
-
Turning Point Secures Positive FDA Feedback For Planned Lung Cancer Drug Submission
Wednesday, July 27, 2022 - 4:45pm | 210Turning Point Therapeutics (NASDAQ: TPTX) has received positive feedback from the U.S. Food and Drug Administration (FDA) at a pre-New Drug Application (NDA) meeting completed in the second quarter. The pre-NDA meeting was convened to discuss its planned NDA for the lead asset Repotrectinib in...
-
FDA Accepts Lexicon's New Drug Application For Review In Heart Failure Setting
Wednesday, July 27, 2022 - 11:20am | 226The U.S. Food and Drug Administration (FDA) has accepted for review Lexicon Pharmaceuticals ‘ (NASDAQ: LXRX) New Drug Application (NDA) for sotagliflozin for the treatment of heart failure. The regulatory agency has assigned a standard review with a PDUFA target action date in May 2023. The...
-
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Tuesday, July 12, 2022 - 5:35am | 2849Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media. Pliant Therapeutics, Inc. (NASDAQ: PLRX) shares surged 159% to close at $23.00 on Monday after the company said its treatment for Idiopathic...
-
Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge
Monday, July 11, 2022 - 2:42pm | 777U.S. stocks traded lower toward the end of trading as investors digested the recent jobs report for the month of June. The Dow traded down 0.30% to 31,242.86 while the NASDAQ fell 1.85% to 11,419.99. The S&P also fell, dropping, 0.92% to 3,863.48. Also check this: GameStop, Levi Strauss And 3...
-
Needham Previews Neurocrine's Upcoming Mid-Stage Data from Essential Tremor Study
Monday, July 11, 2022 - 2:20pm | 257Needham previews the upcoming Phase 2 data readout for Neurocrine Biosciences Inc's (NASDAQ: NBIX) NBI-827104, a t-type calcium channel blocker in essential tremor (ET), by mid-2022. The analyst notes that though NBI-827104 lags behind its competitors, the market...
-
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
Monday, July 11, 2022 - 12:11pm | 1605Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study. La Jolla Pharmaceutical Company (NASDAQ: LJPC) gained 80.9% to $6.13 after Innoviva entered into a definitive...
-
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
Monday, July 11, 2022 - 8:14am | 245Innoviva Inc (NASDAQ: INVA) has agreed to acquire La Jolla Pharmaceutical Company (NASDAQ: LJPC) for $5.95 per share, representing a premium of approximately 70% to the 30-day volume-weighted average price. Innoviva will also pay an incremental $0.28 per share for additional...
-
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Wednesday, July 6, 2022 - 5:21am | 2473Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday. Rubicon Technology, Inc. (NASDAQ: RBCN) shares surged 66.1% to settle at $15.05 on Tuesday after the company announced that it entered into a definitive stock purchase and sale agreement with Janel...
-
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Friday, July 1, 2022 - 4:52am | 2531Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. Ensysce Biosciences...
-
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
Thursday, June 30, 2022 - 12:03pm | 1982Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. NeuroSense Therapeutics Ltd. (...
-
Lexicon Shares Jump 20 Percent Following Positive Results From Mid-Stage Diabetic Neuropathy Study
Wednesday, June 29, 2022 - 4:40pm | 275Lexicon Pharmaceuticals (NASDAQ: LXRX) reported positive topline results from the Phase 2 proof-of-concept study of its lead candidate LX9211 in painful diabetic neuropathy. The RELIEF-DPN-1 is the first of two Phase 2 proof-of-concept study designed to evaluate LX9211 in patients with neuropathic...
-
10 Biggest Price Target Changes For Monday
Monday, June 6, 2022 - 7:45am | 415Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday. Piper Sandler reduced JOANN Inc. (NASDAQ: JOAN) price target from $11 to $6. JOANN shares fell 0.8% to $6.31 in pre-market trading. HC Wainwright & Co. lowered the price...
-
Mid-Afternoon Market Update: Gold Drops 1%; Sprague Resources Shares Spike Higher
Friday, June 3, 2022 - 2:31pm | 790U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.89% to 32,953.50 while the NASDAQ fell 2.44% to 12,016.38. The S&P also fell, dropping, 1.52% to 4,113.52. Also check this: Home Depot And 2 Other Stocks...